Key points are not available for this paper at this time.
The transcription factor GATA-1 is essential for normal erythropoiesis. By examining in vitro-differentiated embryonic stem cells, we showed previously that in the absence of GATA-1, committed erythroid precursors fail to complete maturation and instead undergo apoptosis. The mechanisms by which GATA-1 controls cell survival are unknown. Here we report that in erythroid cells, GATA-1 strongly induces the expression of the anti-apoptotic protein bcl-xL, but not the related proteins bcl-2 and mcl-1. Consistent with a role for bcl-xL in mediating GATA-1-induced erythroid cell survival, in vitro-differentiated bcl-xL-/- embryonic stem cells fail to generate viable mature definitive erythroid cells, a phenotype resembling that of GATA-1 gene disruption. In addition, we show that erythropoietin, which is also required for erythroid cell survival, cooperates with GATA-1 to stimulate bcl-xL gene expression and to maintain erythroid cell viability during terminal maturation. Together, our data show that bcl-xL is essential for normal erythroid development and suggest a regulatory hierarchy in which bcl-xL is a critical downstream effector of GATA-1 and erythropoietin-mediated signals.
Building similarity graph...
Analyzing shared references across papers
Loading...
T. Crimmins Gregory
Howard Hughes Medical Institute
Channing Yu
Broad Institute
Averil Ma
Public Library of Science
Blood
Howard Hughes Medical Institute
Ultragenyx Pharmaceutical (United States)
Building similarity graph...
Analyzing shared references across papers
Loading...
Gregory et al. (Thu,) studied this question.
synapsesocial.com/papers/6a095b3736c3abab5045a82e — DOI: https://doi.org/10.1182/blood.v94.1.87.413k41_87_96
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: